| MFS MERIDIAN EMERGING MARKETS EQUITY RESEARCH FUND W1-USD | RVI EMERGENTES | 43,65% | 75,67% | 55,02% | · |
| BGF EMERGING MARKETS EQUITY INCOME A2 USD | RVI EMERGENTES | 43,62% | 73,08% | 55,24% | 146,58% |
| GENERALI INVESTMENTS SICAV - CENTRAL & EASTERN EUROPEAN EQUITY EX | RVI EMERGENTES EUROPA | 43,61% | 124,88% | 130,03% | 174,19% |
| DWS INVEST ENHANCED COMMODITY STRATEGY LCH | RVI MATERIAS PRIMAS | 43,59% | 42,93% | 51,06% | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 43,59% | 26,05% | · | · |
| BGF EMERGING MARKETS EQUITY INCOME A2 EUR | RVI EMERGENTES | 43,58% | 72,84% | 55,17% | · |
| NINETY ONE GSF ASIAN EQUITY FUND A ACC USD | RVI ASIA EX-JAPÓN | 43,58% | 95,79% | 64,68% | · |
| UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (CHF HEDGED) Q-ACC | RVI EMERGENTES | 43,57% | 84,69% | 30,99% | 122,74% |
| NINETY ONE GSF ASIAN EQUITY FUND IX INC USD | RVI ASIA EX-JAPÓN | 43,56% | 94,32% | 61,58% | · |
| CARMIGNAC PORTFOLIO EMERGENTS FW EUR ACC | RVI EMERGENTES | 43,55% | 73,56% | 46,55% | · |
